The role of pharmacotherapy in the treatment of endometriosis across the lifespan

References

• Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997 Jun;24(2):235–258.
   PubMed Web of Science ®Google Scholar
• Meuleman C, Vandenabeele B, Fieuws S, et al. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009 Jul;92(1):68–74.
   PubMed Web of Science ®Google Scholar
• Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod Oxf Eng. 2012 May;27(5):1292–1299.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Surrey ES, Bonafede M, et al. Health care utilization and costs associated with endometriosis among women with medicaid insurance. J Manag Care Spec Pharm. 2019 May;25(5):566–572.
   PubMed Web of Science ®Google Scholar
• Chen I, Thavorn K, Yong PJ, et al. Hospital-associated cost of endometriosis in canada: a population-based study. J Minim Invasive Gynecol [Internet]. 2019 Sep 12 [cited 2019 Oct 24]. Available from. http://www.sciencedirect.com/science/article/pii/S1553465019311823
   Web of Science ®Google Scholar
• Dunselman GAJ, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod Oxf Eng. 2014 Mar;29(3):400–412.
   PubMed Web of Science ®Google Scholar
• American College of Obstetrics and Gynecology. Practice Bulletin No. 114: management of endometriosis. Obstet Gynecol. 2010 Jul;116(1):223–236.
   PubMedGoogle Scholar
• Endometriosis- ClinicalKey [Internet]. [cited 2019 Nov 10]. Available from: https://www-clinicalkey-com.ccmain.ohionet.org/#!/content/67-s2.0-434776c3-215e-4c20-88c4-40bd8c91529a?scrollTo=%23treatment-heading-29
   Google Scholar
• Institute for clinical and economic review final report highlights limitations in evidence on long-term safety and effectiveness of elagolix for endometriosis, discusses options for insurance coverage criteria [Internet]. ICER. [cited 2019 Nov 10]. Available from: https://icer-review.org/announcements/elagolix-final-report/
   Google Scholar
• Lumsden MA. Prostaglandins in dysmenorrhoea and endometriosis. In: Drife JO, Calder AA, editors. Prostaglandins and the Uterus [Internet]. London: Springer; 1992 [cited 2019 Nov 4]. 45–66. DOI:10.1007/978-1-4471-1931-9_4
   Google Scholar
• Bulun SE. Endometriosis. N Engl J Med. 2009 Jan 15;360(3):268–279.
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod Oxf Eng. 2004 Jan;19(1):160–167.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Remorgida V, Venturini PL. Leone Roberti Maggiore U. Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:117–122.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Leone Roberti Maggiore U, Scala C, et al. Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. Arch Gynecol Obstet. 2013 Mar;287(3):447–453.
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril. 2004 Feb;81(2):290–296.
   PubMed Web of Science ®Google Scholar
• Guo S-W, Wang Y. The prevalence of endometriosis in women with chronic pelvic pain. Gynecol Obstet Invest. 2006;62(3):121–130.
   PubMed Web of Science ®Google Scholar
• Casper RF. Introduction: A focus on the medical management of endometriosis. Fertil Steril. 2017 Mar 1;107(3):521–522.
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Taketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008 Nov;90(5):1583–1588.
   PubMed Web of Science ®Google Scholar
• Harada T, Kosaka S, Elliesen J, et al. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial. Fertil Steril. 2017;108(5):798–805.
   PubMed Web of Science ®Google Scholar
• Muzii L, Di Tucci C, Achilli C, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016 Feb;214(2):203–211.
   PubMed Web of Science ®Google Scholar
• Zorbas KA, Economopoulos KP, Vlahos NF. Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. Arch Gynecol Obstet. 2015 Jul;292(1):37–43.
   PubMed Web of Science ®Google Scholar
• Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2012 Mar;14(3):CD002122.
   Google Scholar
• Römer T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet. 2018 Oct;298(4):747–753.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Nagata C, Hayashi H, et al. Use of dienogest over 53 weeks for the treatment of endometriosis. J Obstet Gynaecol Res. 2015;41(12):1921–1926.
   PubMed Web of Science ®Google Scholar
• Carvalho N, Margatho D, Cursino K, et al. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril. 2018;110(6):1129–1136.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Scala C, Ciccarelli S, et al. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2019 Nov 12:1–5.
   Google Scholar
• Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol. 1999 Jan;93(1):51–58.
   PubMed Web of Science ®Google Scholar
• Del Forno S, Mabrouk M, Arena A, et al. Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: can we avoid surgery? Eur J Obstet Gynecol Reprod Biol. 2019 Jul 1;238:120–124.
   PubMed Web of Science ®Google Scholar
• Becker CM, Gattrell WT, Gude K, et al. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017 Jul;108(1):125–136.
   PubMed Web of Science ®Google Scholar
• Guo S-W. Recurrence of endometriosis and its control. Hum Reprod Update. 2009 Aug;15(4):441–461.
   PubMed Web of Science ®Google Scholar
• Guo S-W, Martin DC. The perioperative period: a critical yet neglected time window for reducing the recurrence risk of endometriosis? Hum Reprod Oxf Eng. 2019 Oct 2;34(10):1858–1865.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vercellini P, Vigano P, et al. Postoperative medical therapy after surgical treatment of endometriosis: from adjuvant therapy to tertiary prevention. J Minim Invasive Gynecol. 2014 Jun;21(3):328–334.
   PubMed Web of Science ®Google Scholar
• Selçuk İ, Bozdağ G. Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature. J Turk Ger Gynecol Assoc. 2013 Jun 1;14(2):98–103.
   PubMedGoogle Scholar
• Pagidas K, Falcone T, Hemmings R, et al. Comparison of reoperation for moderate (stage III) and severe (stage IV) endometriosis-related infertility with in vitro fertilization-embryo transfer. Fertil Steril. 1996 Apr;65(4):791–795.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Scala C, Racca A, et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case-control study. Fertil Steril. 2015 May;103(5):1236–1243.
   PubMed Web of Science ®Google Scholar
• Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015 Mar;103(3):738–743.
   PubMed Web of Science ®Google Scholar
• Pre and post operative medical therapy for endometriosis surgery. PubMed - NCBI [Internet]. [cited 2019 Nov 5]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15266496
   Google Scholar
• Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2004;(3):CD003678.
   PubMedGoogle Scholar
• Abou-Setta AM, Houston B, Al-Inany HG, et al. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD005072.
   PubMed Web of Science ®Google Scholar
• Seracchioli R, Mabrouk M, Frascà C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010 Jul;94(2):464–471.
   PubMed Web of Science ®Google Scholar
• Seracchioli R, Mabrouk M, Frascà C, et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril. 2010 Jan;93(1):52–56.
   PubMed Web of Science ®Google Scholar
• Vlahos N, Vlachos A, Triantafyllidou O, et al. Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study. Fertil Steril. 2013 Nov;100(5):1337–1342.
   PubMed Web of Science ®Google Scholar
• Goodman LR, Goldberg JM, Flyckt RL, et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016 Nov;215(5):589.e1–589.e6.
   Web of Science ®Google Scholar
• Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018;131(3):557–571.
   PubMed Web of Science ®Google Scholar
• Koga K, Takamura M, Fujii T, et al. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015 Oct;104(4):793–801.
   PubMed Web of Science ®Google Scholar
• Donnez J, Squifflet J. Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules. Hum Reprod Oxf Eng. 2010 Aug;25(8):1949–1958.
   PubMed Web of Science ®Google Scholar
• Telimaa S, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 1987 Dec;1(4):363–371.
   PubMedGoogle Scholar
• Godin R, Marcoux V. Vaginally administered danazol: an overlooked option in the treatment of rectovaginal endometriosis? J Obstet Gynaecol Can. 2015 Dec;37(12):1098–1103.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Anserini P, Abbamonte LH, et al. Fertility after bowel resection for endometriosis. Fertil Steril. 2009 Jul;92(1):41–46.
   PubMed Web of Science ®Google Scholar
• Razzi S, Luisi S, Calonaci F, et al. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril. 2007 Oct;88(4):789–794.
   PubMed Web of Science ®Google Scholar
• Cobellis L, Razzi S, Fava A, et al. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril. 2004 Jul;82(1):239–240.
   PubMed Web of Science ®Google Scholar
• Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010 Dec;8(12):CD008475.
   Google Scholar
• Taylor HS, Giudice LC, Lessey BA, et al. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist [Internet]. 2017 [cited 2019 Oct 24]. Available from: https://www.nejm.org/doi/10.1056/NEJMoa1700089?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov
   Google Scholar
• Vercellini P, Viganò P, Barbara G, et al. ‘Luigi Mangiagalli’ endometriosis study group. Elagolix for endometriosis: all that glitters is not gold. Hum Reprod Oxf Eng. 2019 Feb 1;34(2):193–199.
   PubMed Web of Science ®Google Scholar
• Hornstein MD, Surrey ES, Weisberg GW, et al. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol. 1998 Jan;91(1):16–24.
   PubMed Web of Science ®Google Scholar
• DiVasta AD, Feldman HA, Sadler Gallagher J, et al. hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial. Obstet Gynecol. 2015 Sep;126(3):617–627.
   PubMed Web of Science ®Google Scholar
• Guzick DS, Huang L-S, Broadman BA, et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril. 2011 Apr;95(5):1568–1573.
   PubMed Web of Science ®Google Scholar
• Bedaiwy MA, Allaire C, Yong P, et al. Medical management of endometriosis in patients with chronic pelvic pain. Semin Reprod Med. 2017;35(1):38–53.
   PubMed Web of Science ®Google Scholar
• Brown J, Crawford TJ, Allen C, et al. Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev [Internet]. 2017 Jan 23 [cited 2019 Oct 27];2017(1). Available from. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464974/.
   Google Scholar
• Hughes E, Brown J, Collins JJ, et al. Ovulation suppression for endometriosis for women with subfertility. Cochrane Database Syst Rev [Internet]. 2007 [cited 2019 Nov 5]. (3). DOI:10.1002/14651858.CD000155.pub2/full
   Web of Science ®Google Scholar
• Duffy JMN, Arambage K, Correa FJS, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014 Apr;3(4):CD011031.
   Google Scholar
• Rehmer JM, Flyckt RL, Goodman LR, et al. Management of Endometriomas. Obstet Gynecol Surv. 2019 Apr;74(4):232–240.
   PubMed Web of Science ®Google Scholar
• Llarena NC, Falcone T, Flyckt RL. Fertility preservation in women with endometriosis. Clin Med Insights Reprod Health. 2019;13:1179558119873386.
   Web of Science ®Google Scholar
• Sallam HN, Garcia-Velasco JA, Dias S, et al. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006 Jan;25(1):CD004635.
   Google Scholar
• Decleer W, Osmanagaoglu K, Verschueren K, et al. RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Hum Reprod Oxf Eng. 2016;31(9):2017–2023.
   PubMed Web of Science ®Google Scholar
• Tamura H, Yoshida H, Kikuchi H, et al. The clinical outcome of dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. J Ovarian Res. 2019;Dec;12(1):123.
   PubMed Web of Science ®Google Scholar
• Santulli P, Collinet P, Fritel X, et al. Management of assisted reproductive technology (ART) in case of endometriosis related infertility: CNGOF-HAS endometriosis guidelines. Gynecol Obstet Fertil Senol. 2018 Mar;46(3):373–375.
   PubMed Web of Science ®Google Scholar
• Cantor A, Tannus S, Son W-Y, et al. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF. Reprod Biomed Online. 2019 Apr;38(4):520–527.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choo CWKim SK, The effects of letrozole on women with endometriosis undergoing ovarian stimulation for in vitro fertilization. Gynecol Endocrinol off J Int Soc Gynecol Endocrinol. 2019 Aug 7;36(3):257–260.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Viganò P, Benaglia L, et al. Ovarian stimulation and endometriosis progression or recurrence: a systematic review. Reprod Biomed Online. 2019 Feb 1;38(2):185–194.
   PubMed Web of Science ®Google Scholar
• Berlanda N, Vercellini P, Fedele L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Curr Opin Obstet Gynecol. 2010 Aug;22(4):320–325.
   PubMed Web of Science ®Google Scholar
• Matorras R, Elorriaga MA, Pijoan JI, et al. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002 Feb;77(2):303–308.
   PubMed Web of Science ®Google Scholar
• Shakiba K, Bena JF, McGill KM, et al. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008 Jun;111(6):1285–1292.
   PubMed Web of Science ®Google Scholar
• Parker WH, Broder MS, Liu Z, et al. Ovarian Conservation at the time of hysterectomy for benign disease. Obstetrics Gynecol. 2005;106(2):8.
   Web of Science ®Google Scholar
• Namnoum AB, Hickman TN, Goodman SB, et al. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995 Nov;64(5):898–902.
   PubMed Web of Science ®Google Scholar
• Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. p. 1439.
   Google Scholar
• Polyzos NP, Fatemi HM, Zavos A, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol RBE. 2011 Jun;21(9):90.
   Google Scholar
• Shah D. Postmenopausal endometriosis: an enigma revisited. J Life Health. 2014;5(4):163–164.
   PubMedGoogle Scholar
• Gemmell LC, Webster KE, Kirtley S, et al. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017 Jul;23(4):481–500.
   PubMed Web of Science ®Google Scholar
• Barnabei VM, Cochrane BB, Aragaki AK, et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women’s Health Initiative. Obstet Gynecol. 2005 May;105(5 Pt 1):1063–1073.
   PubMed Web of Science ®Google Scholar
• Mueck AO. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone. Climacteric J Int Menopause Soc. 2012 Apr;15(Suppl 1):11–17.
   PubMedGoogle Scholar
• Liu S, Xin X, Hua T, et al. Efficacy of Anti-VEGF/VEGFR agents on animal models of endometriosis: a systematic review and meta-analysis. PloS One. 2016;11(11):e0166658.
   PubMed Web of Science ®Google Scholar
• Ceyhan ST, Onguru O, Fidan U, et al. Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model. Eur J Obstet Gynecol Reprod Biol. 2011 Jan;154(1):100–104.
   PubMed Web of Science ®Google Scholar
• Fu J, Song H, Zhou M, et al. Progesterone receptor modulators for endometriosis. Cochrane Database Syst Rev. 2017 Jul 25;7:CD009881.
   PubMedGoogle Scholar
• Kotlyar A, Taylor HS, D’Hooghe TM. Use of immunomodulators to treat endometriosis. Best Pract Res Clin Obstet Gynaecol. 2019 Oct;60:56–65.
   PubMed Web of Science ®Google Scholar
• Long Q, Zheng H, Liu X, et al. Perioperative intervention by β-Blockade and NF-κB suppression reduces the recurrence risk of endometriosis in mice due to incomplete excision. Reprod Sci. 2019 May 1;26(5):697–708.
   PubMed Web of Science ®Google Scholar